Veterinary Medicine Information website

Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats

Authorised
  • Feline panleucopenia virus, strain MW-1, Live
  • Felid herpesvirus 1, strain G2620A, Live
  • Feline calicivirus, strain F9, Live
Download as PDF

Product identification

Medicine name:
Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats
Active substance:
  • Feline panleucopenia virus, strain MW-1, Live
  • Felid herpesvirus 1, strain G2620A, Live
  • Feline calicivirus, strain F9, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain MW-1, Live
    4.30
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Felid herpesvirus 1, strain G2620A, Live
    5.20
    log10 plaque forming unit(s)
    /
    1.00
    Dose
  • Feline calicivirus, strain F9, Live
    4.60
    log10 plaque forming unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:
  • (ID4) 50 Dose; 50 millilitre(s): Box (Cardboard) with 50 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID2) 10 Dose; 10 millilitre(s): Box (Cardboard) with 10 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID1) 5 Dose; 5 millilitre(s): Box (Cardboard) with 5 Box (Cardboard) each with 1 Bottle (Glass) with 1 millilitre(s) and 1 Bottle (Glass) with 1 Dose
  • (ID3) 25 Dose; 25 millilitre(s): Box (Cardboard) with 25 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID8) 50 Dose; 50 millilitre(s): Box (Kunststoff) with 50 Box (Kunststoff) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID7) 25 Dose; 25 millilitre(s): Box (Kunststoff) with 25 Box (Kunststoff) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID6) 10 Dose; 10 millilitre(s): Box (Kunststoff) with 10 Box (Kunststoff) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID5) 5 Dose; 5 millilitre(s): Box (Kunststoff) with 5 Box (Kunststoff) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 103903
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0240/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 18/03/2024
Download

Package Leaflet

English (PDF)
Published on: 13/03/2026
Download

Summary of Product Characteristics

English (PDF)
Published on: 13/03/2026
Download

2603424-paren-20251101.pdf

English (PDF)
Published on: 27/11/2025
Download